Skip to main content
Clinical Trials/NL-OMON52937
NL-OMON52937
Completed
Not Applicable

Hemodynamic Monitoring with the CardioMEMS PA sensor and Quality of Life in Patients with Chronic Heart Failure: The MONITOR HF Trial - MONITOR HF Trial

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
340
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Written informed consent obtained from subject aged \>18 years
  • 2\. Diagnosis of NYHA\-Class III heart failure with at least 1 (additional) HF
  • hospitalization within 12 months of baseline visit (independent of EF %)
  • 3\. Subjects with reduced EF (HFrEF) should be treated according to National and
  • International (ESC) guidelines for optimal or maximum tolerated doses of HF
  • medication and evaluated for ICD or CRT\-D therapy if indicated.
  • 4\. Subjects with a BMI \<\=35\. Subjects with BMI \>35 will require their chest
  • circumference to be measured at the axillary level \<65 inches (related to
  • distance of the sensor)
  • 5\. Subjects willing and able to comply with the follow\-up requirements of the

Exclusion Criteria

  • 1\. Subjects with an active infection
  • 2\. Subjects with history of recurrent (\>1\) pulmonary embolism or deep vein
  • 3\. Subjects who have had a major cardiovascular event (e.g., myocardial
  • infarction, open heart surgery, stroke) within 2 months
  • 4\. Subjects with Cardiac Resynchronization Device (CRT) implanted \<3 months
  • prior to enrolment and implantation of the sensor (in order to avoid
  • manipulation of lead)
  • 5\. Subjects with a Glomerular Filtration Rate (GFR) \<25 ml/min (obtained within
  • 2 weeks of the baseline visit), refractory to diuretic therapy or on chronic
  • renal dialysis

Outcomes

Primary Outcomes

Not specified

Similar Trials